Derbend Asset Management
- SEC CIK
- 0001874068
- Latest filing
- Apr 30, 2024
NVCR holding history
NovoCure Ltd in every 13F filed by Derbend Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVCR overviewAll 13F holders of NVCRFull Q1 2024 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −4,714−100.0% | Sold out | Holders |
| Q1 2022 | 4,714 | $354.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 4,714 | $354.0K | 0.3% | −894−15.9% | Reduced | Holders |
| Q3 2021 | 5,608 | $651.0K | 0.6% | −181−3.1% | Reduced | Holders |
| Q2 2021 | 5,789 | $1.28M | 1.2% | – | No prior filing | Holders |